HomeTGTX • NASDAQ
add
TG Therapeutics Inc common stock
Previous close
$37.26
Day range
$36.86 - $37.98
Year range
$16.65 - $46.48
Market cap
6.02B USD
Avg Volume
1.77M
P/E ratio
155.55
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 120.86M | 90.40% |
Operating expense | 96.69M | 43.67% |
Net income | 5.06M | 147.26% |
Net profit margin | 4.19 | 124.84% |
Earnings per share | 0.03 | 142.86% |
EBITDA | 8.63M | 193.39% |
Effective tax rate | 7.46% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 276.24M | 31.68% |
Total assets | 656.69M | 75.90% |
Total liabilities | 419.40M | 96.70% |
Total equity | 237.29M | — |
Shares outstanding | 145.82M | — |
Price to book | 22.86 | — |
Return on assets | 3.49% | — |
Return on capital | 4.45% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 5.06M | 147.26% |
Cash from operations | -28.72M | -249.88% |
Cash from investing | -12.93M | -39.75% |
Cash from financing | -6.10M | -61,120.00% |
Net change in cash | -47.75M | -173.61% |
Free cash flow | -27.08M | -1,751.33% |
About
Founded
1993
Headquarters
Website
Employees
352
